165 related articles for article (PubMed ID: 28409832)
1. Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
Strowitzki MJ; Schmidt T; Keppler U; Ritter AS; Mahmoud S; Klose J; Mihaljevic AL; Schneider M; Büchler MW; Ulrich AB
J Surg Oncol; 2017 Aug; 116(2):149-158. PubMed ID: 28409832
[TBL] [Abstract][Full Text] [Related]
2. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
4. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Mudan S
J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
7. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
[TBL] [Abstract][Full Text] [Related]
8. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
11. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
[TBL] [Abstract][Full Text] [Related]
12. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
[TBL] [Abstract][Full Text] [Related]
15. Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?
Pinto Marques H; Barroso E; de Jong MC; Choti MA; Ribeiro V; Nobre AM; Carvalho C; Pawlik TM
J Surg Oncol; 2012 May; 105(6):511-9. PubMed ID: 22065486
[TBL] [Abstract][Full Text] [Related]
16. Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis.
Bergeat D; Rayar M; Mouchel Y; Merdrignac A; Meunier B; Lièvre A; Boudjema K; Sulpice L
Langenbecks Arch Surg; 2017 Feb; 402(1):57-67. PubMed ID: 28084516
[TBL] [Abstract][Full Text] [Related]
17. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
18. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?
Sasaki K; Margonis GA; Andreatos N; Wilson A; Gani F; Amini N; Pawlik TM
HPB (Oxford); 2016 Dec; 18(12):1000-1009. PubMed ID: 27769662
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
20. Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.
Fernández-Moreno MC; Dorcaratto D; Garcés-Albir M; Muñoz E; Arvizu R; Ortega J; Sabater L
J Surg Oncol; 2020 Aug; 122(2):212-225. PubMed ID: 32335938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
